ASP Isotopes Inc. ASPI
2.93
(0.02)
(0.68%)
as of 25 Sep
- Market cap
- $466.1M
- P/E
- 0.0×
Follow ASPI
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | — | — |
P/S ratio |
18.62 | 60.86 | 0.00 | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | — | — |
P/Operating CF |
(24.88) | (67.07) | (27.97) | — | — |
P/B ratio |
1.69 | 4.93 | 3.06 | — | — |
Price to Tangible BV |
1.73 | 5.25 | 3.70 | — | — |
EV/Sales |
13.36 | 54.70 | 0.00 | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | — | — |
EV/Operating CF |
(8.43) | (13.58) | (9.29) | — | — |
EV/FCF |
(6.72) | (8.08) | (6.50) | — | — |
Quick Ratio |
11.72 | 8.87 | 1.56 | 1.23 | 9.74 |
Current Ratio |
12.23 | 9.31 | 1.85 | 1.71 | 10.62 |
Net Debt/EBITDA |
1.98 | 0.99 | 0.45 | 0.32 | 0.80 |
Debt/Assets |
43.84% | 38.55% | 2.46% | 6.21% | 12.44% |
Debt/Equity |
0.83 | 0.71 | 0.04 | 0.08 | 0.15 |
Asset Turnover |
0.08 | 0.07 | 0.02 | 0.00 | — |
Operating CF/Net income |
0.22 | 0.48 | 0.33 | 0.59 | 0.00 |
Capex/Depreciation |
(5.05) | (24.14) | (62.33) | (61.61) | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (111.50%) | (100.33%) | (113.70%) | (62.54%) | 0.00% | |
| (59.12%) | (57.62%) | (81.35%) | (50.36%) | 0.00% | |
ROIC |
(25.32%) | (64.22%) | (86.43%) | (38.84%) | 0.00% |
Return on Tangible Assets |
(43.70%) | (43.33%) | (104.74%) | (51.69%) | (44.16%) |
Average Days of Receivables |
763.50 | 64.74 | 790.78 | — | — |
Research and Development Expense of Revenue |
51.82% | 75.75% | 176.58% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
202.26% | 598.79% | 3,560.37% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.02 | 0.03 | 0.12 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
70.01% | 238.30% | 2,174.02% | 0.00% | — |
Graham Net Nets |
0.37 | 0.09 | 0.03 | — | — |
Graham Number |
0.00 | 0.00 | 0.00 | — | — |
Earnings Yield |
(40.00%) | (14.35%) | (28.16%) | — | — |
Free Cash Flow Yield |
(10.68%) | (11.13%) | (13.46%) | — | — |
Revenue per Share |
0.29 | 0.07 | 0.01 | 0.00 | 0.00 |
Operating CF per Share |
(0.46) | (0.30) | (0.16) | (0.11) | 0.00 |
Capex per Share |
(0.12) | (0.20) | (0.07) | (0.17) | 0.00 |
Free Cash Flow per Share |
(0.57) | (0.50) | (0.23) | (0.28) | 0.00 |
Cash per Share |
4.02 | 1.11 | 0.24 | 0.09 | 0.09 |
Shareholders Equity per Share |
3.17 | 0.92 | 0.57 | 0.37 | 0.17 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.17 | 0.92 | 0.57 | 0.37 | 0.17 |
Free Cash Flow |
(47.43) | (28.07) | (7.74) | (7.41) | 0.00 |
Working Capital |
367.22 | 58.69 | 4.84 | 1.37 | 2.92 |
Capital Expenditures |
(9.65) | (11.37) | (2.33) | (4.47) | 0.00 |
Net Current Asset Value |
164.80 | 22.56 | 1.80 | 0.62 | 2.08 |
EV/EBIT |
0.00 | 0.00 | 0.00 | — | — |
Capex to Sales |
0.40 | 2.74 | 5.38 | 0.00 | 0.00 |
Net Profit Margin |
(734.17%) | (847.35%) | (3,761.25%) | 0.00% | 0.00% |
Price to Operating Income |
0.00 | 0.00 | 0.00 | — | — |
| Other line items | |||||
Depreciation/Fixed assets |
0.06 | 0.02 | 0.00 | 0.01 | 0.00 |
Cash ROIC |
(8.75%) | (26.13%) | (58.82%) | (85.81%) | (30.37%) |
Accounts Receivable Turnover |
0.94 | 4.95 | 0.00 | — | — |
Accounts Payable Turnover |
6.03 | 2.39 | 0.24 | 0.10 | 0.00 |
Inventory Turnover |
35.13 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
102.75 | 146.43 | 1,379.83 | 6,811.83 | 1,123.22 |
Days of Inventory on Hand |
19.60 | 9.47 | 0.00 | 0.00 | 0.00 |
Average Receivables |
25.31 | 0.84 | — | — | — |
Average Payables |
3.39 | 1.07 | 1.23 | 0.71 | — |
Average Inventory |
0.58 | — | — | — | — |
Average Assets |
296.18 | 60.94 | 20.02 | 9.82 | — |
Average Common Equity |
157.03 | 35.00 | 14.32 | 7.91 | — |
Columns are period end dates